Nabriva Gets Initial Nod For $3M Investor Settlement
A Manhattan federal judge gave an initial nod to a $3 million settlement that would end investor claims that biopharmaceutical company Nabriva Therapeutics PLC and four of its executives misrepresented the...To view the full article, register now.
Already a subscriber? Click here to view full article